Tempus AI, Inc. (NASDAQ:TEM) EVP Sells $5,071,893.52 in Stock

Tempus AI, Inc. (NASDAQ:TEM) EVP Erik Phelps sold 61,582 shares of Tempus AI stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $82.36, for a total transaction of $5,071,893.52. Following the completion of the transaction, the executive vice president now directly owns 153,080 shares of the company’s stock, valued at $12,607,668.80. The trade was a 28.69 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Erik Phelps also recently made the following trade(s):

• On Wednesday, February 5th, Erik Phelps sold 5,934 shares of Tempus AI stock. The shares were sold at an average price of $67.57, for a total transaction of $400,960.38.

Tempus AI Stock Performance

TEM stock opened at $68.09 on Friday. Tempus AI, Inc. has a 12 month low of $22.89 and a 12 month high of $91.45. The firm’s 50-day moving average is $50.29 and its 200 day moving average is $51.72. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on TEM shares. TD Cowen reissued a “buy” rating and set a $74.00 price objective (up from $58.00) on shares of Tempus AI in a research note on Wednesday, February 5th. William Blair downgraded Tempus AI from an “outperform” rating to a “market perform” rating in a research report on Wednesday, February 12th. Piper Sandler restated a “neutral” rating and issued a $70.00 price target (up from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Stifel Nicolaus cut shares of Tempus AI from a “buy” rating to a “hold” rating and boosted their price objective for the company from $45.00 to $65.00 in a research report on Monday, November 11th. Finally, Bank of America raised their target price on shares of Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a report on Friday, December 13th. Four equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat, Tempus AI currently has a consensus rating of “Moderate Buy” and a consensus price target of $58.55.

Hedge Funds Weigh In On Tempus AI

A number of institutional investors have recently modified their holdings of the stock. First Horizon Advisors Inc. bought a new position in Tempus AI in the third quarter worth approximately $30,000. Operose Advisors LLC purchased a new stake in shares of Tempus AI in the 4th quarter worth $25,000. Farther Finance Advisors LLC bought a new position in shares of Tempus AI during the 4th quarter worth $34,000. Prestige Wealth Management Group LLC increased its stake in shares of Tempus AI by 910.4% during the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock valued at $36,000 after buying an additional 965 shares during the period. Finally, NewEdge Advisors LLC bought a new stake in shares of Tempus AI in the fourth quarter valued at about $49,000. 24.22% of the stock is owned by hedge funds and other institutional investors.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.